1. Jordan Food & Drug Administration

2. Pharmaceutical Policy Studies Workshop RUD Unit Plan for RUD Unit

3. Workshop First day presentations/Second day group discussion. Topic for discussion: Should there be a National RUD Unit to progress RUD issues in Jordan? If No, how else might RUD be coordinated and facilitated? If Yes, outline five major strategies for the RDU Unit.

4. Then… In what Institution (s) should it reside? What should be the administrative structure? Where might the funding come from? What is the RUD Unit's mandate?

5. Group 1 1- Updating and adopting NDF for EDL. 2- Standard Treatment Guidelines. 3- Drug and Therapeutic Committee Activities. 4- JPA activity related in RUD. 5- Regulation of pharmaceutical promotion.

6. Group 2 1- National Treatment Guidelines. 2- Essential Drug List. 3- Drug and Therapeutics Committee. 4- Monitoring and Quality Assurance. 5- Continuous Education.

7. Group 3 1. Development of evidence-based STG 2. Adopt and implement (EDL) and (JNF) 3. Create DTC in all hospitals 4. Ensure training and CE consumer awareness of RUD 5. Establish a health information system 6. Development of ethical code for drug promotion (depending on WHO ethical code)

8. Group 4 1. Adopt or develop and implement NDF, EDL 2. Adopt or develop STG 3. Establish a research and support unit for RUD 4. Establish a national drug information and pharmacovigilance centre 5. Implement pharmaceutical care program and educate and promote RUD

9. Group 5 1- Development of a National Formulary 2- Development of Essential Drug List 3- Development of Standard Treatment Guidelines 4- Development of Pharmaceutical care program 5- Development of Monitoring and field study systems

10. RUD Unit Structure a. In what Institution should it reside? b. What should be the administrative structure? c. Where does the funding come from? d. What is the RUD Unit's mandate?

11. Group 1 Independent Unit / JPA Department under high level boards of directors Initially international funding, later government public sector funding

12. Group 2 Independent: either JFDA or MOH Board of directors with representatives from MOH, JFDA, RMS, Director Office Funds MOH / JFDA RMS Powers to implement different functions

13. Group 3 Independent unit / JFDA Public and private sector International donors Costs percentage of registration fees Support MoF Mandate Outside the MoH

14. Group 4 JFDA Head of the unit / Directorate plus4 major units. Stakeholders MoH / JFDA / International community.

15. Group 5 Independent / JFDA Administratively independent International institutions and / or within the health care public budget Private sector but with some flexibility in the public sector

16. Now we are on the phase of implementing all what have been mentioned. Starting with forming a Steering Committee of 10 DM and holding a meeting to discuss all the previous recommendations.

17. The Administration does believe that someone has to take the first step if not the JFDA who else???

18. Thank You All